Ito, Hiroyuki http://orcid.org/0000-0002-8143-0082
Matsumoto, Suzuko
Inoue, Hideyuki
Izutsu, Takuma
Kusano, Eiji
Antoku, Shinichi
Yamasaki, Tomoko
Mori, Toshiko
Togane, Michiko
Article History
Received: 20 February 2023
Accepted: 8 May 2023
First Online: 30 May 2023
Declarations
:
: H Ito has received lecture fees from Eli Lilly Japan KK, Novo Nordisk Pharma Ltd., Sumitomo Pharma Co., Ltd. and Boehringer Ingelheim. S Matsumoto, H Inoue, T Izutsu, E Kusano, S Antoku, T Yamasaki, T Mori, and M Togane have no conflicts of interest.
: The study was conducted in accordance with the principles expressed in the 2008 Declaration of Helsinki. The Ethics Committee of Edogawa Hospital approved the study protocol (approved numbers: 2015-18 and 2022-1, approved date: July 6, 2015 and November 24, 2021, respectively) and waived the need for written informed consent because the data were analyzed anonymously for this analysis based on information stored in the hospital. The trial is retrospectively registered on UMIN-CTR, identifier UMIN000047632 (1 May, 2022).